在骨科创伤患者的静脉血栓栓塞预防中开发和评估临床药剂师领导的全程管理模型:随机对照试验的研究方案
Ruping Ni1, Ping Huang2, Zhaowen Gao3
1Department of Clinical Pharmacy, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian Province, 353000, China.
Trials
|February 10, 2026
概括
本研究评估了一种由药剂师领导的模型,用于预防骨科创伤患者的静脉血栓栓塞 (VTE). 它的目的是通过全面的管理策略来改善VTE预防的结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 创伤外科 手术 创伤外科
背景情况:
- 静脉血栓塞栓症 (VTE) 是骨科创伤患者的重大风险,特别是下肢和部骨折患者.
- 药物预防是标准的,但需要平衡疗效与出血风险.
- 在骨科创伤中,药剂师领导的综合性VTE预防模型的证据有限.
研究的目的:
- 评估临床药剂师主导的临床治疗模式在骨科创伤患者的VTE预防中的有效性.
- 通过综合护理产生高质量的证据来改善患者的治疗结果.
主要方法:
- 一个单中心,前性,随机对照试验,涉及170名骨科创伤患者.
- 干预组接受了药剂师主导的管理 (风险评估,教育,监测,后续).
- 对照组接受了标准护理;主要结局是90天内VTE发生率.
主要成果:
- 关于VTE发病率的初级结局数据正在等待分析.
- 二次结果包括出血事件和药物坚持.
- 这项研究已注册 (ChiCTR2500107932),数据分析是治疗意图.
结论:
- 这项试验将提供关键的证据,证明药剂师主导的VTE预防在骨科创伤中的影响.
- 预计这些发现将为临床实践提供信息,并优化患者护理途径.
相关概念视频
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
354
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
354
Venous Thrombosis IV: Nursing Management
269
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
269
Statistical Software for Data Analysis and Clinical Trials
1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Esophageal Perforation-II: Clinical Manifestations and Management
746
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
746


